AGL 39.54 Decreased By ▼ -0.46 (-1.15%)
AIRLINK 127.90 Decreased By ▼ -1.16 (-0.9%)
BOP 6.83 Increased By ▲ 0.08 (1.19%)
CNERGY 4.70 Increased By ▲ 0.21 (4.68%)
DCL 8.50 Decreased By ▼ -0.05 (-0.58%)
DFML 41.57 Increased By ▲ 0.75 (1.84%)
DGKC 82.95 Increased By ▲ 1.99 (2.46%)
FCCL 33.02 Increased By ▲ 0.25 (0.76%)
FFBL 74.00 Decreased By ▼ -0.43 (-0.58%)
FFL 11.92 Increased By ▲ 0.18 (1.53%)
HUBC 110.74 Increased By ▲ 1.16 (1.06%)
HUMNL 14.45 Increased By ▲ 0.70 (5.09%)
KEL 5.23 Decreased By ▼ -0.08 (-1.51%)
KOSM 7.65 Decreased By ▼ -0.07 (-0.91%)
MLCF 39.00 Increased By ▲ 0.40 (1.04%)
NBP 64.00 Increased By ▲ 0.49 (0.77%)
OGDC 194.25 Decreased By ▼ -0.44 (-0.23%)
PAEL 25.77 Increased By ▲ 0.06 (0.23%)
PIBTL 7.35 Decreased By ▼ -0.04 (-0.54%)
PPL 155.35 Decreased By ▼ -0.10 (-0.06%)
PRL 25.94 Increased By ▲ 0.15 (0.58%)
PTC 18.00 Increased By ▲ 0.50 (2.86%)
SEARL 82.55 Increased By ▲ 3.90 (4.96%)
TELE 7.75 Decreased By ▼ -0.11 (-1.4%)
TOMCL 33.26 Decreased By ▼ -0.47 (-1.39%)
TPLP 8.51 Increased By ▲ 0.11 (1.31%)
TREET 16.50 Increased By ▲ 0.23 (1.41%)
TRG 56.90 Decreased By ▼ -1.32 (-2.27%)
UNITY 27.63 Increased By ▲ 0.14 (0.51%)
WTL 1.38 Decreased By ▼ -0.01 (-0.72%)
BR100 10,556 Increased By 111.1 (1.06%)
BR30 31,363 Increased By 173.8 (0.56%)
KSE100 98,462 Increased By 663.8 (0.68%)
KSE30 30,705 Increased By 224.2 (0.74%)

Women who have had breast cancer often forego pregnancy for fear that it will increase the chances of their cancer coming back. But a study of more than 1,200 women, presented on Saturday at the American Society of Clinical Oncology (ASCO) meeting in Chicago, now shows they may be able to have a baby without boosting the risk that their cancer will return.
"These findings provide reassurance to breast cancer survivors that having a baby after a breast cancer diagnosis may not increase the chance of their cancer coming back," said Dr Erica Mayer, a breast cancer expert from Dana Farber Cancer Institute speaking on behalf of ASCO.
Women who have had breast cancer are the least likely of all cancer survivors to have a baby after a diagnosis, due in large part to fears that the high production of hormones released during pregnancy might cause latent cancer cells to start growing. This is a particular concern for women with estrogen-receptor positive (ER-positive) breast cancer, which is fed by the hormone estrogen. Women with these cancers take estrogen-blocking drugs for five and sometimes 10 years to keep their cancer in check.
For those women, pregnancy would mean taking a pause from the therapy, which has been shown to keep cancer from returning. The study included 1,207 women under age 50 who were diagnosed with non-metastatic breast cancer before 2008. Most (57 percent) had ER-positive breast cancer. Of the total, 333 women became pregnant. Each of these women was matched to three women with similar cancers who did not become pregnant.
After about 10 years of follow-up, there was no significant difference in cancer recurrence between the women who had a baby and those who did not. "Our findings confirm that pregnancy after breast cancer should not be discouraged, even for ER-positive cancer," said Dr Matteo Lambertini of the Institute Jules Bordet in Brussels, who led the study. Among women with ER-positive cancers, there was no difference in overall survival.

Copyright Reuters, 2017

Comments

Comments are closed.